Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Urologic Oncology|May 12, 2010
An update on targeted therapy in metastatic renal cell carcinomaGiuseppe Lombardi, Fable Zustovich, Martin Donach, et al.
Anticancer Research|October 23, 2009
A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant gliomaFable Zustovich, Giuseppe Lombardi, Alessandro Della Puppa, et al.
American Journal of Clinical Oncology|October 28, 2009
Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approachesGiuseppe Lombardi, Fable Zustovich, Maria Ornella Nicoletto, et al.
Clinical Chemistry and Laboratory Medicine|September 26, 2012
CA125 reference values change in male and postmenopausal female subjectsGiuseppe Cartei, Francesco Cartei, Martina Bertin, et al.
International Journal of Clinical Oncology|June 17, 2008
Cardiac metastasis from renal cell carcinoma without inferior vena involvement: a review of the literature based on a case report. Two different patterns of spread?Fable Zustovich, Fedra Gottardo, Luca De Zorzi, et al.
Anticancer Research|January 25, 2008
A phase II study of gemcitabine at fixed infusion rate of 10 mg/m2/min with or without immunotherapy in advanced renal cancerFable Zustovich, Giuseppe Cartei, Davide Pastorelli, et al.
Tumori|December 16, 2006
Multiple-target chemotherapy (LV-modulated 5-FU bolus and continuous infusion, oxaliplatin, CPT- 11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I-II studyAndrea Bonetti, Marta Zaninelli, Emilia Durante, et al.
BJU International|May 28, 2011
Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trialOrazio Caffo, Teodoro Sava, Evi Comploj, et al.
American Journal of Clinical Oncology|July 13, 2010
Tolerability of PLD/oxaliplatin regimen in recurrent ovarian cancer patients with previous fragility to carboplatin/paclitaxel treatmentMaurizia Dalla Palma, Giuseppe Lombardi, Martin E Donach, et al.
Biomed Research International|May 10, 2014
The combination of carmustine wafers and fotemustine in recurrent glioblastoma patients: a monoinstitutional experienceGiuseppe Lombardi, Alessandro Della Puppa, Fable Zustovich, et al.
Pageof 7